Head-to-head · Value Score
Trimi Health vs Rejuve Meds
Two GLP-1 deals, scored on the same six factors. Trimi Health lands a Value Score of 89, Rejuve Meds a 75. Here's who gives you the honest lower price — and where each one bites back.
Trimi Health
#3 · Grade A · Great Deal
Est. first month
$99/mo
Save ~93% vs brand-nameRejuve Meds
#135 · Grade C+ · Fair Price
Est. first month
From $165/mo (starting dose, compounded)
Save ~88% vs brand-nameThe verdict
Trimi Health takes it on Value Score, 89 to 75 — an est. $99/mo first month, with no teaser step-up baked in. Rejuve Meds isn't out of it: Shoppers wanting transparent, low-cost compounded GLP-1 with no membership fees and HSA/FSA eligibility.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | Trimi Health | Rejuve Meds |
|---|---|---|
| Value Score | 89 (A) | 75 (C+) |
| Est. first month | $99/mo | From $165/mo (starting dose, compounded) |
| Save vs brand-name | ~93% | ~88% |
| Semaglutide | $99/mo | From $165/mo (starting dose, compounded) |
| Tirzepatide | $125/mo | From $265/mo (starting dose, compounded) |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | Coverage not published |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
Trimi Health
The ultra-budget pick: two-digit semaglutide and a $125 tirzepatide — one of the lowest flat tirz stickers on the whole board — shipped to all 50 states.
Why it's a deal
- Ultra-budget on both molecules — $99 semaglutide and a class-low $125 tirzepatide, flat with no teaser step-up
- Tirzepatide at $125/mo undercuts most of the flat-fee field on the priciest molecule
- Nationwide 50-state reach, so the low price isn't gated to a handful of states
The fine print
- Not LegitScript-certified — do your own pharmacy diligence before you buy on price alone
- Compounded injectable only — no FDA-approved brand-name or oral/sublingual route
- Newer brand with a thin public track record
Rejuve Meds
Rejuve Meds (Rejuve, Inc.) is a GLP-1 weight-loss telehealth service offering doctor-guided compounded semaglutide at $165/mo and dual-action compounded tirzepatide (GLP-1/GIP) at $265/mo, with no…
Why it's a deal
- Transparent published pricing: compounded semaglutide $165/mo, tirzepatide $265/mo
- No membership fees — everything is included; free shipping
- HSA/FSA eligible; intro pricing from $85 for the first month
- Doctor-guided programs with personalized care
- Names a "Rejuve Meds Pharmacy Network" for fulfillment
The fine print
- Individual compounding pharmacies not named (only a "pharmacy network")
- Prescribing medical group not named
- States of operation not published
- Not LegitScript-certified (no certification displayed)
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores Trimi Health is ranked on the Trimi Health alternatives board, and the same list for the other side is on alternatives to Rejuve Meds.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.